文献速递复苏、休克与脓毒症心脑血管急症

高级生命支持对院外心脏骤停且接受除颤患者的影响

Effects of advanced life support on patients who suffered cardiac arrest outside of hospital and were defibrillated.
PubMed 文献 · Am J Emerg Med · 2017-07-05
一句话结论对已除颤的院外心脏骤停患者,高级气道管理和/或院前肾上腺素与1个月生存率及神经功能良好出院率降低相关。

该前瞻性观察研究纳入2005至2013年日本37,873例符合标准的院外心脏骤停患者,采用分层logistic回归、条件logistic回归及时间依赖倾向性匹配分析。结果显示,在倾向匹配患者中,高级气道管理和/或院前肾上腺素使用与1个月生存率降低(校正OR 0.88,95%CI 0.80-0.97)及CPC 1-2降低(校正OR 0.56,95%CI 0.48-0.66)相关。未接受肾上腺素的患者中,高级气道管理与1个月生存率降低(校正OR 0.89,95%CI 0.81-0.98)及CPC 1-2降低(校正OR 0.54,95%CI 0.46-0.64)相关,而肾上腺素使用与结局无关。作者认为,在已除颤的院外心脏骤停患者中,高级气道管理和/或肾上腺素与长期生存率降低相关,且高级气道管理获益低于肾上腺素,但初始电击反应者比例很低,外部真实性可能有限。

要点

  • 在已除颤的院外心脏骤停患者中,高级气道管理和/或院前肾上腺素与1个月生存率降低相关(校正OR 0.88,95%CI 0.80-0.97)。
  • 上述干预同样与1个月神经功能良好(CPC 1-2)率降低相关(校正OR 0.56,95%CI 0.48-0.66)。
  • 未接受肾上腺素的患者中,高级气道管理与1个月生存率降低(校正OR 0.89,95%CI 0.81-0.98)及CPC 1-2降低(校正OR 0.54,95%CI 0.46-0.64)相关。
  • 未接受肾上腺素的患者中,肾上腺素使用与所测结局无关。
  • 研究人群中初始电击反应者比例很低,作者指出外部真实性可能有限。

适用人群与场景

  • 2005至2013年日本院外心脏骤停且接受除颤的患者。

研究设计与关键结果

  • 研究类型为前瞻性观察研究,纳入2005至2013年日本院外心脏骤停病例,共分析37,873例符合纳入标准的患者,采用分层logistic回归、条件logistic回归及时间依赖倾向性匹配。
  • 在倾向匹配患者中,高级气道管理和/或院前肾上腺素使用与1个月生存率降低相关(校正OR 0.88,95%CI 0.80-0.97),与CPC 1-2降低相关(校正OR 0.56,95%CI 0.48-0.66)。
  • 未接受肾上腺素的患者中,高级气道管理与1个月生存率降低相关(校正OR 0.89,95%CI 0.81-0.98),与CPC 1-2降低相关(校正OR 0.54,95%CI 0.46-0.64)。
  • 未接受肾上腺素的患者中,肾上腺素使用与所测结局无关。

证据类型、等级与局限

  • 证据类型为前瞻性观察研究。
  • 局限:研究人群中初始电击反应者比例很低,作者指出外部真实性可能有限。

对床旁实践的改变

  • 作者认为,在已除颤的院外心脏骤停患者中,高级气道管理和/或肾上腺素与长期生存率降低相关,且高级气道管理获益低于肾上腺素。
  • 作者指出,由于初始电击反应者比例很低,研究结果的外部真实性可能有限。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The effects and relative benefits of advanced airway management and epinephrine on patients with out-of-hospital cardiac arrest (OHCA) who were defibrillated are not well understood.

METHODS: This was a prospective observational study. Using data of all out-of-hospital cardiac arrest cases occurring between 2005 and 2013 in Japan, hierarchical logistic regression and conditional logistic regression along with time-dependent propensity matching were performed. Outcome measures were survival and minimal neurological impairment [cerebral performance category (CPC) 1 or 2] at 1month after the event.

RESULTS: We analyzed 37,873 cases that met the inclusion criteria. Among propensity-matched patients, advanced airway management and/or prehospital epinephrine use was related to decreased rates of 1-month survival (adjusted odds ratio 0.88, 95% confidence interval 0.80 to 0.97) and CPC (1, 2) (adjusted odds ratio 0.56, 95% confidence interval 0.48 to 0.66). Advanced airway management was related to decreased rates of 1-month survival (adjusted odds ratio 0.89, 95% confidence interval 0.81to 0.98) and CPC (1, 2) (adjusted odds ratio 0.54, 95% confidence interval 0.46 to 0.64) in patients who did not receive epinephrine, whereas epinephrine use was not related to the outcome measures.

CONCLUSIONS: In defibrillated patients with OHCA, advanced airway management and/or epinephrine are related to reduced long-term survival, and advanced airway management is less beneficial than epinephrine. However, the proportion of patients with OHCA who responded to an initial shock was very low in the study subjects, and the external validity of our findings might be limited.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Hagihara A, Onozuka D, Nagata T, et al. Effects of advanced life support on patients who suffered cardiac arrest outside of hospital and were defibrillated. Am J Emerg Med. 2017. PMID: 28698134. doi:10.1016/j.ajem.2017.07.018

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。